Innate immunity to TB: a druggable balancing act
- PMID: 22304907
- DOI: 10.1016/j.cell.2012.01.026
Innate immunity to TB: a druggable balancing act
Abstract
Tobin and colleagues show that both inhibition and excessive production of the inflammatory mediator TNFα impact the pathogenesis of tuberculosis (TB) and the response to therapy. Identifying a critical role for the genetically determined balance between pro- and anti-inflammatory eicosanoids in regulating TNFα levels provides a roadmap to tailored TB treatment based on host genotype.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment on
-
Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.Cell. 2012 Feb 3;148(3):434-46. doi: 10.1016/j.cell.2011.12.023. Cell. 2012. PMID: 22304914 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
